{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:43:18Z","timestamp":1791614598147,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA043055"],"award-info":[{"award-number":["R21 DA043055"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA043055"],"award-info":[{"award-number":["R21 DA043055"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01 AT010508"],"award-info":[{"award-number":["R01 AT010508"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01 AT010508"],"award-info":[{"award-number":["R01 AT010508"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Addict Rep"],"DOI":"10.1007\/s40429-022-00446-3","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T09:03:44Z","timestamp":1664442224000},"page":"660-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Potential of N-acetyl Cysteine in Behavioral Addictions and Related Compulsive and Impulsive Behaviors and Disorders: a Scoping Review"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-0957","authenticated-orcid":false,"given":"Norman R.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo A.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"issue":"5","key":"446_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/00952990.2010.491884","volume":"36","author":"JE Grant","year":"2010","unstructured":"\u2022 Grant JE, Potenza MN, Weinstein A, Gorelick DA. Introduction to behavioral addictions. Am J Drug Alcohol Abuse. 2010;36(5):233\u201341. This article reviews common clinical features, epidemiologic characteristics, neurobiological processes, diagnostic considerations, and treatment of behavioral addictions.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"446_CR2","first-page":"150","volume":"11","author":"M Brand","year":"2020","unstructured":"Brand M, Rumpf HJ, Demetrovics Z, M\u00dcller A, Stark R, King DL, et al. Which conditions should be considered as disorders in the International Classification of Diseases (ICD-11) designation of \u201cother specified disorders due to addictive behaviors\u201d? J Behav Addict. 2020;11(2):150\u20139.","journal-title":"J Behav Addict."},{"key":"446_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric A","year":"2013","unstructured":"American Psychiatric A. Diagnostic and statistical manual of mental disorders. American Psychiatric Association; 2013."},{"issue":"2","key":"446_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1037\/a0032389","volume":"27","author":"MN Potenza","year":"2013","unstructured":"Potenza MN. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013;27(2):380\u201392.","journal-title":"Psychol Addict Behav"},{"key":"446_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2019.06.032","volume":"104","author":"M Brand","year":"2019","unstructured":"Brand M, Wegmann E, Stark R, M\u00fcller A, W\u00f6lfling K, Robbins TW, et al. The interaction of person-affect-cognition-execution (I-PACE) model for addictive behaviors: update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors. Neurosci Biobehav Rev. 2019;104:1\u201310.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"446_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1874473711104030201","volume":"4","author":"AN Gearhardt","year":"2011","unstructured":"Gearhardt AN, White MA, Potenza MN. Binge eating disorder and food addiction. Curr Drug Abuse Rev. 2011;4(3):201\u20137.","journal-title":"Curr Drug Abuse Rev"},{"issue":"11","key":"446_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/00004583-200211000-00015","volume":"41","author":"MK Nixon","year":"2002","unstructured":"Nixon MK, Cloutier PF, Aggarwal S. Affect regulation and addictive aspects of repetitive self-injury in hospitalized adolescents. J Am Acad Child Adolesc Psychiatry. 2002;41(11):1333\u201341.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"446_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1556\/2006.2022.00005","volume":"11","author":"M Himelein-Wachowiak","year":"2022","unstructured":"Himelein-Wachowiak M, Giorgi S, Kwarteng A, Schriefer D, Smitterberg C, Yadeta K, et al. Getting \u201cclean\u201d from nonsuicidal self-injury: experiences of addiction on the subreddit r\/selfharm. J Behav Addict. 2022;11(1):128\u201339.","journal-title":"J Behav Addict"},{"issue":"3","key":"446_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40429-014-0021-z","volume":"1","author":"A Meule","year":"2014","unstructured":"Meule A, Gearhardt AN. Five years of the Yale food addiction scale: taking stock and moving forward. Curr Addict Rep. 2014;1(3):193\u2013205.","journal-title":"Curr Addict Rep"},{"issue":"3","key":"446_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1556\/2006.2021.00027","volume":"10","author":"C Liu","year":"2021","unstructured":"Liu C, Rotaru K, Lee RSC, Tiego J, Suo C, Y\u00fccel M, et al. Distress-driven impulsivity interacts with cognitive inflexibility to determine addiction-like eating. J Behav Addict. 2021;10(3):534\u20139.","journal-title":"J Behav Addict"},{"issue":"4","key":"446_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1556\/JBA.2.2013.015","volume":"2","author":"LR Schreiber","year":"2013","unstructured":"Schreiber LR, Odlaug BL, Grant JE. The overlap between binge eating disorder and substance use disorders: diagnosis and neurobiology. J Behav Addict. 2013;2(4):191\u20138.","journal-title":"J Behav Addict"},{"issue":"2","key":"446_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1556\/2006.7.2018.22","volume":"7","author":"K R\u00f8mer Thomsen","year":"2018","unstructured":"R\u00f8mer Thomsen K, Callesen MB, Hesse M, Kvamme TL, Pedersen MM, Pedersen MU, et al. Impulsivity traits and addiction-related behaviors in youth. J Behav Addict. 2018;7(2):317\u201330.","journal-title":"J Behav Addict"},{"issue":"2","key":"446_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","volume":"184","author":"DL Lafleur","year":"2006","unstructured":"Lafleur DL, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison RT, et al. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology. 2006;184(2):254\u20136.","journal-title":"Psychopharmacology"},{"issue":"9","key":"446_CR14","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","volume":"30","author":"K Chakrabarty","year":"2005","unstructured":"Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology. 2005;30(9):1735\u201340.","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"446_CR15","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.3390\/ijerph19116370","volume":"19","author":"DK Lee","year":"2022","unstructured":"Lee DK, Lipner SR. The potential of N-acetylcysteine for treatment of trichotillomania, excoriation disorder, onychophagia, and onychotillomania: an updated literature review. Int J Environ Res Public Health. 2022;19(11):6370.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"446_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s43440-021-00283-7","volume":"73","author":"I Smaga","year":"2021","unstructured":"Smaga I, Frankowska M, Filip M. N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research. Pharmacol Rep. 2021;73(5):1205\u201319.","journal-title":"Pharmacol Rep"},{"issue":"7","key":"446_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ajad.12620","volume":"26","author":"MS Duailibi","year":"2017","unstructured":"Duailibi MS, Cordeiro Q, Brietzke E, Ribeiro M, LaRowe S, Berk M, et al. N-acetylcysteine in the treatment of craving in substance use disorders: systematic review and meta-analysis. Am J Addict. 2017;26(7):660\u20136.","journal-title":"Am J Addict"},{"issue":"2","key":"446_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40263-014-0142-x","volume":"28","author":"EA McClure","year":"2014","unstructured":"McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014;28(2):95\u2013106.","journal-title":"CNS Drugs"},{"issue":"8","key":"446_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"\u2022 Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10(8):561\u201372. This article reviews and details the mechanisms by which glutamate dysregulation affects addiction and relapse behavior.","journal-title":"Nat Rev Neurosci"},{"key":"446_CR20","doi-asserted-by":"crossref","unstructured":"Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev. 2015;55:294\u2013321.","DOI":"10.1016\/j.neubiorev.2015.04.015"},{"issue":"7","key":"446_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","volume":"66","author":"JE Grant","year":"2009","unstructured":"Grant JE, Odlaug BL, Won KS. N-Acetylcysteine, a Glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756\u201363.","journal-title":"Arch Gen Psychiatry"},{"key":"446_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.psychres.2017.02.024","volume":"251","author":"MA Nocito Echevarria","year":"2017","unstructured":"\u2022 Nocito Echevarria MA, Andrade Reis T, Ruffo Capatti G, Siciliano Soares V, da Silveira DX, Fidalgo TM. N-acetylcysteine for treating cocaine addiction - a systematic review. Psychiatry Res. 2017;251:197\u2013203. This paper reviews preclinical and clinical trials (from before 2016) assessing NAC\u2019s effects in cocaine use disorder. The reviewed papers suggest that NAC is effective in reducing reinstatement of cocaine-seeking in prelinical trials and preventing relapse in clinical trials.","journal-title":"Psychiatry Res"},{"issue":"2","key":"446_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1590\/1516-4446-2013-1244","volume":"36","author":"E Asevedo","year":"2014","unstructured":"Asevedo E, Mendes AC, Berk M, Brietzke E. Systematic review of N-acetylcysteine in the treatment of addictions. Braz J Psychiatry. 2014;36(2):168\u201375.","journal-title":"Braz J Psychiatry"},{"issue":"5","key":"446_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s43440-021-00283-7","volume":"73","author":"I Smaga","year":"2021","unstructured":"Smaga I, Frankowska M, Filip M. N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research. Pharmacol Rep. 2021;73(5):1205\u201319.","journal-title":"Pharmacol Rep"},{"issue":"17","key":"446_CR25","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2174\/1381612824666180417124919","volume":"24","author":"F di Michele","year":"2018","unstructured":"di Michele F, Siracusano A, Talamo A, Niolu C. N-acetyl cysteine and vitamin D supplementation in treatment resistant obsessive-compulsive disorder patients: a general review. Curr Pharm Des. 2018;24(17):1832\u20138.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"446_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/cap.2013.0137","volume":"24","author":"S Marler","year":"2014","unstructured":"Marler S, Sanders KB, Veenstra-VanderWeele J. N-acetylcysteine as treatment for self-injurious behavior in a child with autism. J Child Adolesc Psychopharmacol. 2014;24(4):231\u20134.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"446_CR27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/phar.2238","volume":"39","author":"A Sabus","year":"2019","unstructured":"Sabus A, Feinstein J, Romani P, Goldson E, Blackmer A. Management of self-injurious behaviors in children with neurodevelopmental disorders: a pharmacotherapy overview. Pharmacotherapy. 2019;39(6):645\u201364.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"446_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajmg.a.36306","volume":"164a","author":"JL Miller","year":"2014","unstructured":"Miller JL, Angulo M. An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome. Am J Med Genet A. 2014;164a(2):421\u20134.","journal-title":"Am J Med Genet A."},{"issue":"4","key":"446_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/WNF.0000000000000352","volume":"42","author":"F Kili\u00e7","year":"2019","unstructured":"Kili\u00e7 F, Kele\u015f S. Repetitive behaviors treated with N-acetylcysteine: case series. Clin Neuropharmacol. 2019;42(4):139\u201341.","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"446_CR30","first-page":"149","volume":"25","author":"MJ Pesko","year":"2020","unstructured":"Pesko MJ, Burbige EM, Sannar EM, Beresford C, Rogers C, Ariefdjohan M, et al. The use of N-acetylcysteine supplementation to decrease irritability in four youths with autism spectrum disorders. J Pediatr Pharmacol Ther. 2020;25(2):149\u201354.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"11","key":"446_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","volume":"71","author":"AY Hardan","year":"2012","unstructured":"Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, et al. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012;71(11):956\u201361.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"446_CR32","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","volume":"23","author":"K McFarland","year":"2003","unstructured":"McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2003;23(8):3531\u20137.","journal-title":"J Neurosci"},{"issue":"7","key":"446_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nn1069","volume":"6","author":"DA Baker","year":"2003","unstructured":"Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6(7):743\u20139.","journal-title":"Nat Neurosci"},{"issue":"10","key":"446_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","volume":"65","author":"LA Knackstedt","year":"2009","unstructured":"Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, et al. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009;65(10):841\u20135.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"446_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","volume":"34","author":"M Berk","year":"2013","unstructured":"Berk M. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci (Regular ed). 2013;34(3):167\u201377.","journal-title":"Trends Pharmacol Sci (Regular ed)"},{"issue":"1","key":"446_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.9758\/cpn.2015.13.1.12","volume":"13","author":"G Oliver","year":"2015","unstructured":"Oliver G, Dean O, Camfield D, Blair-West S, Ng C, Berk M, et al. N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. Clin Psychopharmacol Neurosci. 2015;13(1):12\u201324.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"446_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1037\/a0034518","volume":"22","author":"L Rennert","year":"2014","unstructured":"Rennert L. DSM-5 gambling disorder: Prevalence and characteristics in a substance use disorder sample. Exp Clin Psychopharmacol. 2014;22(1):50\u201365.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"446_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10899-009-9135-y","volume":"25","author":"M Toce-Gerstein","year":"2009","unstructured":"Toce-Gerstein M, Gerstein DR, Volberg RA. The NODS\u2013CLiP: a rapid screen for adult pathological and problem gambling. J Gambl Stud. 2009;25(4):541\u201355.","journal-title":"J Gambl Stud"},{"issue":"6","key":"446_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/archfami.8.6.515","volume":"8","author":"AV Pasternak Iv","year":"1999","unstructured":"Pasternak Iv AV. Prevalence of gambling disorders in a primary care setting. Arch Fam Med. 1999;8(6):515\u201320.","journal-title":"Arch Fam Med"},{"issue":"9806","key":"446_CR40","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/S0140-6736(10)62185-X","volume":"378","author":"DC Hodgins","year":"2011","unstructured":"Hodgins DC, Stea JN, Grant JE. Gambling disorders. The Lancet. 2011;378(9806):1874\u201384.","journal-title":"The Lancet"},{"issue":"2\u20133","key":"446_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000115782","volume":"56","author":"C Nordin","year":"2007","unstructured":"Nordin C, Gupta RC, Sjodin I. Cerebrospinal fluid amino acids in pathological gamblers and healthy controls. Neuropsychobiology. 2007;56(2\u20133):152\u20138.","journal-title":"Neuropsychobiology"},{"key":"446_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/109786","volume":"2014","author":"M Pettorruso","year":"2014","unstructured":"Pettorruso M, De Risio L, Martinotti G, Di Nicola M, Ruggeri F, Conte G, et al. Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives. Biomed Res Int. 2014;2014:1\u201311.","journal-title":"Biomed Res Int"},{"issue":"4","key":"446_CR43","first-page":"250","volume":"23","author":"DW Black","year":"2011","unstructured":"Black DW, McNeilly DP, Burke WJ, Shaw MC, Allen J. An open-label trial of acamprosate in the treatment of pathological gambling. Ann Clin Psychiatry. 2011;23(4):250\u20136.","journal-title":"Ann Clin Psychiatry"},{"key":"446_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fpsyt.2012.00102","volume":"3","author":"M Pettorruso","year":"2012","unstructured":"Pettorruso M, Martinotti G, Di Nicola M, Onofrj M, Di Giannantonio M, Conte G, et al. Amantadine in the treatment of pathological gambling: a case report. Front Psychiatry. 2012;3:102.","journal-title":"Front Psychiatry"},{"issue":"3","key":"446_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22029","volume":"68","author":"A Thomas","year":"2010","unstructured":"Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M. Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol. 2010;68(3):400\u20134.","journal-title":"Ann Neurol"},{"issue":"4","key":"446_CR46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00213-010-1994-5","volume":"212","author":"JE Grant","year":"2010","unstructured":"Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology. 2010;212(4):603\u201312.","journal-title":"Psychopharmacology"},{"issue":"1","key":"446_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","volume":"28","author":"PN Dannon","year":"2005","unstructured":"Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol. 2005;28(1):6\u201310.","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"446_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","volume":"62","author":"JE Grant","year":"2007","unstructured":"Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry (1969). 2007;62(6):652\u20137.","journal-title":"Biol Psychiatry (1969)"},{"key":"446_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4088\/JCP.13m08411","volume":"75","author":"JE Grant","year":"2014","unstructured":"Grant JE, Odlaug BL, Chamberlain SR, Potenza MN, Schreiber LRN, Donahue CB, et al. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014;75:39\u201345.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"446_CR50","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1525-1497.2002.10812.x","volume":"17","author":"MN Potenza","year":"2002","unstructured":"Potenza MN, Fiellin DA, Heninger GR, Rounsaville BJ, Mazure CM. Gambling. J Gen Intern Med. 2002;17(9):721\u201332.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"446_CR51","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/npp.2012.66","volume":"37","author":"L Schmaal","year":"2012","unstructured":"Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology. 2012;37(9):2143\u201352.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"446_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12900","volume":"26","author":"EA Woodcock","year":"2021","unstructured":"\u2022\u2022 Woodcock EA, Lundahl LH, Khatib D, Stanley JA, Greenwald MK. N -acetylcysteine reduces cocaine-seeking behavior and anterior cingulate glutamate\/glutamine levels among cocaine-dependent individuals. Addict Biol. 2021;26(2): e12900. This clinical trial of 12 participants with cocaine use disorder assessed the use of 3600 mg\/day of NAC on cocaine-primed increases in cocaine-seeking and on brain glutamate levels measured with proton magnetic resonance spectroscopy. NAC significantly reduced cocaine-seeking in the test and reduced rACC glutamate and glutamine levels.","journal-title":"Addict Biol"},{"issue":"2","key":"446_CR53","first-page":"188","volume":"2","author":"SW Yip","year":"2017","unstructured":"Yip SW, Morie KP, Xu J, Constable RT, Malison RT, Carroll KM, et al. Shared microstructural features of behavioral and substance addictions revealed in areas of crossing fibers. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(2):188\u201395.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"1","key":"446_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/adb.12492","volume":"23","author":"SW Yip","year":"2018","unstructured":"Yip SW, Worhunsky PD, Xu J, Morie KP, Constable RT, Malison RT, et al. Gray-matter relationships to diagnostic and transdiagnostic features of drug and behavioral addictions. Addict Biol. 2018;23(1):394\u2013402.","journal-title":"Addict Biol"},{"key":"446_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugalcdep.2014.09.013","volume":"145","author":"PD Worhunsky","year":"2014","unstructured":"Worhunsky PD, Malison RT, Rogers RD, Potenza MN. Altered neural correlates of reward and loss processing during simulated slot-machine fMRI in pathological gambling and cocaine dependence. Drug Alcohol Depend. 2014;145:77\u201386.","journal-title":"Drug Alcohol Depend"},{"key":"446_CR56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.drugalcdep.2017.05.025","volume":"178","author":"PD Worhunsky","year":"2017","unstructured":"Worhunsky PD, Potenza MN, Rogers RD. Alterations in functional brain networks associated with loss-chasing in gambling disorder and cocaine-use disorder. Drug Alcohol Depend. 2017;178:363\u201371.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"446_CR57","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1556\/2006.2020.00093","volume":"9","author":"NR Greenberg","year":"2020","unstructured":"Greenberg NR, Zhai ZW, Hoff RA, Krishnan-Sarin S, Potenza MN. Problematic shopping and self-injurious behaviors in adolescents. J Behav Addict. 2020;9(4):1068\u201378.","journal-title":"J Behav Addict"},{"key":"446_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpsychires.2020.02.016","volume":"124","author":"LC Farhat","year":"2020","unstructured":"Farhat LC, Roberto AJ, Wampler J, Steinberg MA, Krishnan-Sarin S, Hoff RA, et al. Self-injurious behavior and gambling-related attitudes, perceptions and behaviors in adolescents. J Psychiatr Res. 2020;124:77\u201384.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"446_CR59","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.4088\/JCP.v66n1121d","volume":"66","author":"C Pittenger","year":"2005","unstructured":"Pittenger C, Krystal JH, Coric V. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. J Clin Psychiatry. 2005;66(11):1492\u20133.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"446_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/cap.2017.0032","volume":"28","author":"KR Cullen","year":"2018","unstructured":"\u2022\u2022 Cullen KR, Klimes-Dougan B, Westlund Schreiner M, Carstedt P, Marka N, Nelson K, et al. N-acetylcysteine for nonsuicidal self-injurious behavior in adolescents: an open-label pilot study. J Child Adolesc Psychopharmacol. 2018;28(2):136\u201344. This is an open-label clinical trial of 35 female adolescents in which NAC significantly decreased SIB frequency and depression scores.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"446_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109778","volume":"99","author":"KR Cullen","year":"2020","unstructured":"\u2022\u2022 Cullen KR, Schreiner MW, Klimes-Dougan B, Eberly LE, LaRiviere LL, Lim KO, et al. Neural correlates of clinical improvement in response to N-acetylcysteine in adolescents with non-suicidal self-injury. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99: 109778. This study used fMRI to measure resting state connectivity in 35 female adolescents using NAC to reduce SIB. They found that decreases in SIB frequency and depression scores correlated with increased amygdala-frontal connectivity and decreased amygdala-SMA connectivity.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"446_CR62","first-page":"210007","volume":"6","author":"SA Sahasrabudhe","year":"2021","unstructured":"Sahasrabudhe SA, Silamongkol T, Park YW, Colette A, Eberly LE, Klimes-Dougan B, et al. Identifying biological signatures of N-acetylcysteine for non-suicidal self-injury in adolescents and young adults. J Psychiatr Brain Sci. 2021;6:210007.","journal-title":"J Psychiatr Brain Sci"},{"issue":"7","key":"446_CR63","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ijo.2016.31","volume":"40","author":"MM Hurley","year":"2016","unstructured":"\u2022\u2022 Hurley MM, Resch JM, Maunze B, Frenkel MM, Baker DA, Choi S. N-acetylcysteine decreases binge eating in a rodent model. Int J Obes (Lond). 2016;40(7):1183\u20136. This preclinical study of binge eating disorder showed that NAC significantly reduced high-carbohydrate\/high-fat binge eating episodes in rats.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"446_CR64","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1111\/ejn.15321","volume":"54","author":"D Sketriene","year":"2021","unstructured":"Sketriene D, Battista D, Perry CJ, Sumithran P, Lawrence AJ, Brown RM. N-acetylcysteine reduces addiction-like behaviour towards high-fat high-sugar food in diet-induced obese rats. Eur J Neurosci. 2021;54(3):4877\u201387.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"446_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.eatbeh.2012.11.001","volume":"14","author":"AI Guerdjikova","year":"2013","unstructured":"Guerdjikova AI, Blom TJ, Mori N, McElroy SL. N-acetylcysteine in bulimia nervosa\u2013open-label trial. Eat Behav. 2013;14(1):87\u20139.","journal-title":"Eat Behav"},{"issue":"2","key":"446_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1521-0391.2009.00027.x","volume":"19","author":"KM Gray","year":"2010","unstructured":"Gray KM, Watson NL, Carpenter MJ, Larowe SD. N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010;19(2):187\u20139.","journal-title":"Am J Addict"},{"issue":"1","key":"446_CR67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12991-021-00369-9","volume":"20","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang S, Hong X, Lu S, Tang S, Shen Y, et al. A case of trichotillomania with binge eating disorder: combined with N-acetylcysteine synergistic therapy. Ann Gen Psychiatry. 2021;20(1):46.","journal-title":"Ann Gen Psychiatry"},{"issue":"5","key":"446_CR68","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamapsychiatry.2016.0060","volume":"73","author":"JE Grant","year":"2016","unstructured":"Grant JE, Chamberlain SR, Redden SA, Leppink EW, Odlaug BL, Kim SW. N-Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiat. 2016;73(5):490\u20136.","journal-title":"JAMA Psychiat"},{"key":"446_CR69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jpsychires.2022.07.066","volume":"154","author":"AW Blum","year":"2022","unstructured":"\u2022 Blum AW, Grant JE. N-acetylcysteine in the treatment of compulsive sexual behavior disorder: A case series. J Psychiatr Res. 2022;154:203\u20136. This is a recently published case series of 8 patients treated with NAC for compulsive sexual behavior. Five out of 8 of the participants had significant reduction in Y-BOCS score modified for compulsive sexual behavior, suggesting the therapy may be effective.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"446_CR70","first-page":"51","volume":"3","author":"TW Fong","year":"2006","unstructured":"Fong TW. Understanding and managing compulsive sexual behaviors. Psychiatry (Edgmont). 2006;3(11):51\u20138.","journal-title":"Psychiatry (Edgmont)"},{"key":"446_CR71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fnbeh.2019.00227","volume":"13","author":"KM Moore","year":"2019","unstructured":"Moore KM, Oelberg WL, Glass MR, Johnson MD, Been LE, Meisel RL. Glutamate Afferents from the medial prefrontal cortex mediate nucleus accumbens activation by female sexual behavior. Front Behav Neurosci. 2019;13:227.","journal-title":"Front Behav Neurosci"},{"issue":"7","key":"446_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102419","volume":"9","author":"V Voon","year":"2014","unstructured":"Voon V, Mole TB, Banca P, Porter L, Morris L, Mitchell S, et al. Neural correlates of sexual cue reactivity in individuals with and without compulsive sexual behaviours. PLoS ONE. 2014;9(7): e102419.","journal-title":"PLoS ONE"},{"issue":"2","key":"446_CR73","first-page":"119","volume":"24","author":"JE Grant","year":"2012","unstructured":"Grant JE, Odlaug BL, Mooney M, O\u2019Brien R, Kim SW. Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry. 2012;24(2):119\u201326.","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"446_CR74","doi-asserted-by":"publisher","first-page":"276","DOI":"10.9758\/cpn.2018.16.3.276","volume":"16","author":"S-H Paik","year":"2018","unstructured":"Paik S-H, Choi MR, Kwak SM, Bang SH, Kim D-J. Decreased serum glutamate levels in male adults with Internet gaming disorder: a pilot study. Clin Psychopharmacol Neurosci. 2018;16(3):276\u201381.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"7","key":"446_CR75","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3174\/ajnr.A6632","volume":"41","author":"HS Seo","year":"2020","unstructured":"Seo HS, Jeong EK, Choi S, Kwon Y, Park HJ, Kim I. Changes of neurotransmitters in youth with Internet and smartphone addiction: a comparison with healthy controls and changes after cognitive behavioral therapy. AJNR Am J Neuroradiol. 2020;41(7):1293\u2013301.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"446_CR76","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.euroneuro.2018.08.004","volume":"28","author":"NA Fineberg","year":"2018","unstructured":"Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, Gr\u00fcnblatt E, et al. Manifesto for a European research network into problematic usage of the Internet. Eur Neuropsychopharmacol. 2018;28(11):1232\u201346.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"446_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pscychresns.2009.05.004","volume":"174","author":"S Yang","year":"2009","unstructured":"Yang S, Salmeron BJ, Ross TJ, Xi ZX, Stein EA, Yang Y. Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - a (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy. Psychiatry Res. 2009;174(3):171\u20136.","journal-title":"Psychiatry Res"},{"key":"446_CR78","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1038\/s41380-020-0828-z","volume":"26","author":"EJE Engeli","year":"2020","unstructured":"Engeli EJE, Zoelch N, Hock A, Nordt C, Hulka LM, Kirschner M, et al. Impaired glutamate homeostasis in the nucleus accumbens in human cocaine addiction. Mol Psychiatry. 2020;26:5277\u201385.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"446_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2020.41","volume":"33","author":"TM Galyuk","year":"2021","unstructured":"Galyuk TM, Loonen AJM. Putative role of vitamin D in the mechanism of alcoholism and other addictions \u2013 a hypothesis. Acta Neuropsychiatrica. 2021;33(1):1\u20138.","journal-title":"Acta Neuropsychiatrica"},{"issue":"11","key":"446_CR80","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.3390\/ijerph19116910","volume":"19","author":"B Dresp-Langley","year":"2022","unstructured":"Dresp-Langley B, Hutt A. Digital addiction and sleep. Int J Environ Res Public Health. 2022;19(11):6910.","journal-title":"Int J Environ Res Public Health."},{"key":"446_CR81","doi-asserted-by":"crossref","unstructured":"Trinko JR, Land BB, Solecki WB, Wickham RJ, Tellez LA, Maldonado-Aviles J, et al. Vitamin D3: a role in dopamine circuit regulation, diet-induced obesity, and drug consumption. eNeuro. 2016;3(2):ENEURO.0122-15.2016.","DOI":"10.1523\/ENEURO.0122-15.2016"}],"container-title":["Current Addiction Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40429-022-00446-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40429-022-00446-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40429-022-00446-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:23:56Z","timestamp":1669969436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40429-022-00446-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":81,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1007\/s40429-022-00446-3","relation":{},"ISSN":["2196-2952"],"issn-type":[{"value":"2196-2952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"20 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest with the content of this manuscript. Dr. Potenza has consulted for Opiant Therapeutics, Game Day Data, Baria-Tek, the Addiction Policy Forum, AXA and Idorsia Pharmaceuticals; has been involved in a patent application with Yale University and Novartis; has received research support from Mohegan Sun Casino and the National Center for Responsible Gaming; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse-control disorders or other health topics; has consulted for and\/or advised gambling and legal entities on issues related to impulse-control\/addictive disorders; has provided clinical care in a problem gambling services program; has performed grant reviews for research-funding agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. The other authors do not report disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}